General

Revenue Leakage in Massachusetts Pulmonary Practices: Where the Money Is Going and How to Get It Back

Pulmonary Practices

If you run or manage a pulmonary or critical care practice in Massachusetts, you already know that getting paid for the care you deliver is not simple. Between the complexity of payer contracts, the intensity of prior authorization requirements, and the documentation demands unique to pulmonary medicine, your revenue cycle carries more risk than almost any other specialty. Our pulmonary billing services help practices navigate these challenges while improving billing accuracy and reimbursement.

But here is what most practices do not fully appreciate: the revenue leakage happening inside their billing operation is largely invisible. It does not announce itself as a denial. It does not show up as a rejected claim. It quietly accumulates in aging AR, underpaid remittances, missed charges, and documentation gaps that close every appeal window before anyone realizes one was open.

This post is about making that invisible leakage visible — specifically for pulmonary and critical care practices operating in Massachusetts, where the payer mix, regulatory environment, and managed care landscape create distinct challenges that generic RCM advice simply does not address. Effective critical care coding & billing services can help identify these gaps and strengthen the overall revenue cycle.

If your collections have plateaued, your AR days are creeping up, or you simply have a gut feeling that you are not capturing everything you have earned, this is for you.

The Massachusetts Payer Landscape: Why It Creates Unique Billing Pressure

Massachusetts is not a typical state for healthcare billing. It has one of the most complex payer environments in the country, shaped by a combination of dominant commercial carriers, a significant MassHealth managed care presence, and a high concentration of academic medical centers that influence how independent practices are reimbursed and credentialed.

Blue Cross Blue Shield of Massachusetts is the dominant commercial payer in the state and carries some of the most specific documentation and authorization requirements of any BCBS plan nationally. What passes through a BCBS plan in another state may trigger a medical necessity review or outright denial under BCBS MA. Pulmonary procedures — pulmonary function testing, bronchoscopies, thoracentesis, sleep study interpretation — are all subject to payer-specific clinical criteria that differ materially from CMS guidelines.

MassHealth, the state’s Medicaid program, has shifted aggressively toward managed care over the past decade. Most MassHealth beneficiaries are now enrolled in one of several Accountable Care Organization (ACO) plans or managed care organizations, each with their own prior authorization rules, formularies, and claim submission requirements. Billing for a MassHealth managed care patient requires knowing which MCO they are enrolled with — and billing to the wrong entity is one of the most common and easily avoidable sources of revenue leakage in Massachusetts practices.

Harvard Pilgrim, Tufts Health Plan, and Aetna all maintain significant market share in the state, each with distinct utilization management policies for pulmonary services. The result is a billing environment where a single standardized workflow applied across all payers will reliably leave money on the table — not because the care was not delivered, but because the claim was not constructed for the payer receiving it.

The Six Most Common Revenue Leakage Points in Massachusetts Pulmonary Practices

Based on AR reviews conducted across pulmonary and critical care practices throughout New England, these are the leakage patterns that appear most consistently.

1. Pulmonary Function Testing Billed Without Supporting Documentation

Pulmonary function tests (PFTs) are among the most frequently denied services in pulmonary billing, and the denial is almost never about whether the test was performed. It is about whether the documentation supports the medical necessity criteria the payer requires to pay for it.

BCBS MA, for example, requires that PFT documentation include the clinical indication, the referring or ordering provider’s notes supporting the indication, and in some cases a documented history of the patient’s response to prior therapy. Claims submitted without this documentation — even when the test is entirely appropriate — are denied for medical necessity.

The leakage here is compounded by the fact that PFT denials often go unworked past the appeal deadline. PFTs are high-volume, relatively low unit cost, and tend to fall lower in the denial worklist priority than hospital-based procedures. The result is that practices write off dozens of PFT denials per month — each one individually manageable, collectively significant.

2. Critical Care Time Documentation That Does Not Survive Audit

Critical care billing (CPT 99291 and 99292) is one of the highest-risk billing areas in all of medicine — not because it is frequently denied on first submission, but because it is frequently targeted in post-payment audits and recoupment reviews.

CMS and commercial payers require that critical care time be documented with specificity: the total time spent, what that time included (interpretation of results, direct patient management, care coordination), and confirmation that the time involved high-complexity medical decision-making. Physician notes that simply state “60 minutes of critical care provided” without supporting detail do not meet this standard.

Massachusetts practices with significant ICU, step-down, or hospital-based pulmonary programs are particularly exposed here. A recoupment demand for three years of critical care claims that do not meet documentation standards can represent a six-figure liability. The billing revenue from those claims has already been spent. The leakage, in this case, flows in reverse — and it arrives as a demand letter, not a denial.

3. Sleep Study Billing Errors: HSAT vs. PSG Misclassification

Pulmonary practices that interpret sleep studies — whether in-lab polysomnography (PSG) or home sleep apnea testing (HSAT) — face a billing environment where the correct code selection depends on multiple variables: the type of study, the number of channels recorded, whether scoring was performed by a technician or directly by the physician, and the payer’s own coverage policy for each study type.

BCBS MA and Harvard Pilgrim have specific coverage policies for HSAT that differ from Medicare’s. Some plans require that HSAT be ordered by a sleep specialist; others require documented failure of behavioral interventions before a diagnostic study is covered. Billing without confirming payer-specific criteria is a reliable source of denials that are difficult to overturn on appeal because the clinical criteria were never met at the point of ordering — not just at the point of billing.

Misclassification between PSG and HSAT codes — or between split-night and full-night studies — creates overpayment risk as well as underpayment. Both cost money. One costs it now; the other costs it during the next audit cycle.

4. Prior Authorization Gaps That Show Up as Medical Necessity Denials

This is one of the most consistently misdiagnosed denial categories in pulmonary billing. A claim comes back with a CO-50 or CO-4 denial code — medical necessity — and the billing team works it as a coding or documentation problem. They query the physician, add more clinical detail to the appeal, and resubmit. The appeal is denied again.

What they missed: the authorization that was obtained covered a different procedure code than what was ultimately billed. The procedure evolved during the encounter — a diagnostic bronchoscopy became a therapeutic one, or a planned thoracentesis required imaging guidance that was not on the original auth. The payer is not denying the medical necessity of the procedure. They are denying that the authorized procedure matches the billed procedure. That is an authorization gap, not a clinical documentation gap.

Fixing this requires mapping billed CPT codes back to authorized CPT codes before the claim goes out — not after it comes back denied. Practices that do not have this reconciliation step in their billing workflow will see this pattern repeat indefinitely, because the root cause never gets addressed.

5. MassHealth MCO Billing Errors: Wrong Payer, Right Patient

As noted earlier, most MassHealth beneficiaries in Massachusetts are now enrolled in managed care plans rather than fee-for-service MassHealth. This means that billing the MassHealth fee-for-service program for a patient who is enrolled in a MassHealth MCO will result in a denial — not because the patient is ineligible, but because the claim went to the wrong payer.

This sounds simple enough to avoid, but it is remarkably common. MCO enrollment changes. Patients do not always know which plan they are enrolled in. Eligibility verification systems that check MassHealth as a payer category do not always drill down to the specific MCO — and when they do not, the claim goes to the wrong place and ages until someone notices.

Practices with high MassHealth volume — common in community-based pulmonary practices in Eastern Massachusetts, Springfield, and Worcester — are particularly exposed. The fix is real-time MCO enrollment verification at scheduling, not at billing. By the time billing touches the claim, the encounter has already happened and the documentation is already written. Verifying MCO enrollment at that point is reactive. Verifying it at scheduling is preventive.

6. Underpayments Accepted as Payment in Full

Short pays — claims paid at less than the contracted rate — are among the most silent forms of revenue leakage in any specialty, and pulmonary medicine is no exception. A claim is submitted, an EOB arrives showing payment, and the workflow closes. Nobody compares the payment against the contracted fee schedule. The underpayment becomes permanent.

This happens for several reasons. Payer fee schedules are updated periodically and billing systems do not always reflect the current contracted rate. Modifiers affect reimbursement in ways that payment posters do not always audit. Bundling logic applied by the payer reduces payment below what the contract allows for separately billable services.

In pulmonary billing, where procedure mix includes both high-value hospital-based procedures and high-volume office-based services, the cumulative impact of systematic underpayments can be substantial. A practice processing 1,500 claims per month with a 10% underpayment rate on complex procedures is leaving tens of thousands of dollars on the table every month — money that was earned, billed, and then quietly accepted at the wrong amount.

The AR Aging Problem: Why Denial Age Predicts Collection Probability

One of the most quantifiable forms of revenue leakage is also one of the most preventable: denials that sit unworked until they age past the point of recovery.

The data on this is clear. Denials worked within seven days of receipt collect at rates between 85 and 92 percent. The same denials worked at 31 to 60 days collect at 50 to 62 percent. After 60 days, collection probability falls to 28 to 40 percent. And 65 percent of denials are never resubmitted at all — they simply age to write-off.

For Massachusetts pulmonary practices, this matters for a specific reason: BCBS MA and many Massachusetts commercial payers have appeal windows that are shorter than the national average for some procedure types. A denial that sits in a worklist for 45 days may have already passed the contractual appeal deadline. At that point, the only option is a waiver request — and those are rarely granted.

The practices that recover the most from their denial inventory are not the ones that appeal most aggressively. They are the ones that work denials fastest, with an assigned owner and a documented action plan at the point of denial — not after it has aged through a backlog.

There is a second cost to aging denials that rarely appears on a report: context decay. The staff member who could have resolved a denial in five minutes on day three needs forty-five minutes on day forty-five because the authorization fax is gone, the call notes have been overwritten, and the physician who made the clinical decision has moved on to other cases. Freshness of the denial and freshness of the context are both depreciating assets. Most denial worklists only track one of them.

What an AR Review Actually Reveals: A Real-World Pattern

When we conduct AR reviews for pulmonary practices, the findings follow a consistent pattern regardless of practice size or market. The surface metrics — clean claim rate, days in AR, denial rate by volume — often look acceptable. It is the layer underneath that tells the real story.

Charge lag between service date and claim submission is frequently longer than practices realize. In pulmonary medicine, where hospital-based services, physician office visits, and procedure-based care all coexist in the same billing operation, charges from inpatient encounters are often the last to be posted — sometimes 10 to 14 days after the date of service. By the time those claims are submitted, payer timely filing windows are already narrowing.

Denial distributions by payer reveal patterns that individual denial reports obscure. A practice may have a 12 percent overall denial rate, but 35 percent of BCBS MA claims for pulmonary function testing may be denying — a payer-specific pattern that demands a payer-specific response, not a generic billing process improvement.

Underpayment analysis consistently surfaces a gap between contracted rates and actual reimbursement that practices have accepted as normal. In one review of a Massachusetts pulmonary practice with three providers, systematic underpayment on bronchoscopy and thoracentesis procedures had gone undetected for over a year. The practice had been billing correctly. The payer had been paying consistently below contract. The workflow never caught it because payment posting was treated as the end of the revenue cycle rather than one step in a verification process.

The common thread across all of these findings: revenue leakage does not look like failure. It looks like normal operations. That is what makes it so persistent and so expensive.

Building a Revenue Cycle That Makes Leakage Visible

The practices that consistently outperform on collections are not doing more work than those that underperform. They have built systems and workflows that surface leakage before it becomes a write-off. There are five operational elements that distinguish high-performing pulmonary RCM programs from those that leave revenue behind.

  • Payer-specific eligibility and authorization verification at scheduling, not at billing. By the time a claim reaches billing, every prior auth gap and eligibility error is already baked in. The only way to prevent those errors from becoming denials is to catch them before the patient is seen.
  • CPT-to-authorization reconciliation before claim submission. Every claim should be checked against the authorization on file to confirm that what was billed is what was authorized. Procedure changes during the encounter need to trigger a same-day authorization update, not a post-denial appeal.
  • Denial age tracking with assigned ownership and escalation triggers. Every denial should have an owner the day it arrives, a documented action plan, and an escalation threshold — not a place in a queue where it will age unnoticed until the appeal window closes.
  • Payment variance monitoring against contracted rates. Payment posting should include a comparison of the amount paid against the contracted amount for that procedure and that payer. Systematic underpayments need to be identified and disputed, not accepted.
  • Regular AR reviews to identify systemic patterns. Denial rate by payer, charge lag by provider, underpayment rate by procedure — these are the metrics that reveal where the leakage is concentrated. Without them, every billing problem looks isolated. With them, the patterns are obvious.

The Cost of Doing Nothing

Revenue leakage in a pulmonary practice rarely announces itself as a crisis. It presents as a plateau — collections that are steady but have not grown despite increased patient volume, AR days that are acceptable but not improving, a vague sense that the numbers should be better than they are.

The cost of inaction compounds over time. A practice losing 8 to 12 percent of collectible revenue to leakage — a conservative estimate for practices without payer-specific billing workflows — is writing off hundreds of thousands of dollars per year in revenue that was earned, documented, and never recovered.

In Massachusetts, where practice overhead is among the highest in the country and reimbursement rates have not kept pace with operating costs, that gap is not sustainable. Practices that do not close it through better revenue cycle management will eventually close it through reduced staffing, reduced services, or reduced access — none of which is the outcome anyone went into medicine to deliver.

The question is not whether revenue leakage exists in your practice. It does, in every practice. The question is whether you have the visibility to see it — and the workflow to stop it.

How PulmoCare RCM Helps Massachusetts Pulmonary Practices Recover Lost Revenue

PulmoCare RCM specializes exclusively in pulmonary and critical care billing. That focus matters because pulmonary billing is not general medical billing applied to a different specialty — it is a discipline that requires deep familiarity with the procedure mix, the documentation requirements, the payer-specific policies, and the denial patterns unique to this specialty.

Our work with Massachusetts practices is built around a single premise: you cannot fix what you cannot see. We start with an AR review that surfaces the leakage patterns specific to your practice — by payer, by procedure, by provider, and by denial category. From there, we build the workflows that make leakage visible before it becomes a write-off.

If you are a pulmonary or critical care practice in Massachusetts and you are not certain your revenue cycle is capturing everything you have earned, a conversation costs nothing. An AR review often pays for itself in the first month of recovered revenue.

Reach out to PulmoCare RCM to schedule a complimentary AR review and find out where your revenue is going.

Leave a Reply

Your email address will not be published. Required fields are marked *